About this trial
The investigators aim to understand the interplay and neural structures involved with decision--making and movement for participants with mild cognitive impairment. Rapidly deciding and acting becomes bottlenecked with mild cognitive impairment and Alzheimer's, leading to detrimental outcomes such as falling and car crashes. The investigators work will have a tangible impact by discovering sensitive biomarkers to detect disease onset and pave the way for informed and effective neurorehabilitation.
Eligibility criteria
Qualifiers
age 45 - 90 years
Perfect or corrected vision
Ability to reach
Neurotypical Age-Matched control participants - No history of neurological disorders or injury.
Disqualifiers
Any injury or condition that impacts reaching
Traumatic brain injury, such as concussion, in the last 6 months.
Neurotypical Age-Matched control participants: Modified Telephone Interview for Cognitive Status (TICS-m) score < 34
Mild Cognitive Impairment participants: Modified Telephone Interview for Cognitive Status (TICS-m) score > 34
Trial design
Treatments tested in this trial
- Reaching Movements
Treatment groups
Sponsors and collaborators
University of Delaware
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of General Medical Sciences (NIGMS)
Collaborator